| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1a990a7fcf6f797c2c5bcd821f96c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c046c23921d049b928bb55ba822403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abd27386386db401505702f12bb83825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff1fb5deccbb7d69c1f7f26b2df1b2c0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 |
| filingDate |
2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b7582e9f89a6da173f24a9e470820b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ade323eabcb5c4d3c02cf2872c14e00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a840045944976448507167188688e14d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_872f49050ec6a64eb815dfa68565d50e |
| publicationDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005103255-A1 |
| titleOfInvention |
Formylpeptide receptor (fpr) as a target for anti-malignant glioma therapy |
| abstract |
The present invention relates, e.g., to a method for inhibiting a formylpeptide receptor (FPR)-mediated activity of a glioma cell expressing FPR, comprising contacting the cell with an effective amount of an agent that inhibits expression and/or activity of the FPR. The cell can be in vitro or in vivo. Also disclosed are inhibitory agents and pharmaceutical compositions for carrying out this method; diagnostic methods for identifying highly malignant glioma cells; and a method for identifying an agent that inhibits an FPR-mediated activity of a glioma cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011045352-A3 |
| priorityDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |